COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
- PMID: 32881895
- PMCID: PMC7470382
- DOI: 10.1371/journal.pmed.1003252
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
Erratum in
-
Correction: COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.PLoS Med. 2020 Oct 23;17(10):e1003445. doi: 10.1371/journal.pmed.1003445. eCollection 2020 Oct. PLoS Med. 2020. PMID: 33095768 Free PMC article.
Abstract
Nicholas White and coauthors discuss chloroquine and hydroxychloroquine pharmacology in the context of possible treatment of SARS-CoV-2 infection.
Conflict of interest statement
NJW is a member of the PLoS Medicine Editorial Board. The authors declare that no other competing interests exist.
Figures
References
-
- Coatney GR. Pitfalls in a discovery: the chronicle of chloroquine. The American Journal of Tropical Medicine and Hygiene. 1963;12(2):121–128. - PubMed
-
- Berliner RW, Earle DP, Taggart JV, Zubrod CG, Welch WJ, Conan NJ, et al. Studies on the chemotherapy of the human malarias. VI. The physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-aminoquinoline. The Journal of clinical investigation. 1948;27(3):98–107. - PMC - PubMed
-
- World Health Organisation Scientific Group on the Chemotherapy of Malaria. Advances in malaria chemotherapy: report of a WHO scientific group. vol. 711 World Health Organization; 1984.
-
- CEIC. China CN production. 2020 [cited 2020 May 20]. Available from: https://www.ceicdata.com/en/china/pharmaceutical-production-ytd-antipara....
-
- World Health Organization. Guidelines for the treatment of malaria. World Health Organization; 2015.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
